| Home | E-Submission | Sitemap | Editorial Office |  
top_img
   
REVIEW
The fibrogenic process and the unleashing of acute-on-chronic liver failure
Acute-on-chronic liver failure (ACLF) is a life-threatening condition characterized by a rapid deterioration of previously well-compensated chronic liver diseases. One of the main obstacles in ACLF is the lack of knowledge of the pathogenesis and specific broad-spectrum treatmen...
ORIGINAL ARTICLE
A survey on transarterial chemoembolization refractoriness and a real-world treatment pattern for hepatocellular carcinoma in Korea
Background/Aims: Transarterial chemoembolization (TACE) is a standard treatment for intermediate-stage hepatocellular carcinoma (HCC), but there is much controversy about TACE refractoriness. The aim of this study was to identify trends in the actual clinical application of TACE...
Current Issue
Volume 26(1); Jan 2020
Volume 25(4); December 2019
Volume 25(3); September 2019
Volume 25(2); June 2019
Volume 25(1); March 2019
RSS feed
Reviews
1 Immunologic strategies and outcomes in ABO-incompatible living donor liver transplantation
Jongwook Oh, Jong Man Kim
Clin Mol Hepatol.2020;26(1):1-6.   Published online March 26, 2019     
DOI: https://doi.org/10.3350/cmh.2019.0023
                              
7 The fibrogenic process and the unleashing of acute-on-chronic liver failure
Guillermo Nahúm López-Sánchez, Mayra Dóminguez-Pérez, Misael Uribe, Natalia Nuño-Lámbarri
Clin Mol Hepatol.2020;26(1):7-15.   Published online June 14, 2019     
DOI: https://doi.org/10.3350/cmh.2019.0011
                                 Cited By 1
16 Extrahepatic manifestations of hepatitis E virus: An overview
Fotios S. Fousekis, Ioannis V. Mitselos, Dimitrios K. Christodoulou
Clin Mol Hepatol.2020;26(1):16-23.   Published online October 11, 2019     
DOI: https://doi.org/10.3350/cmh.2019.0082
                                 Cited By 1
Original Articles
24 A survey on transarterial chemoembolization refractoriness and a real-world treatment pattern for hepatocellular carcinoma in Korea
Jae Seung Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Jin Sil Seong, Kwang-Hyub Han, Do Young Kim
Clin Mol Hepatol.2020;26(1):24-32.   Published online May 20, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0065
                              Supplementary      
33 Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection
Hye Soo Kim, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Young Nyun Park, Dai Hoon Han, Kyung Sik Kim, Jin Sub Choi, Gi Hong Choi, Hyon-Suk Kim
Clin Mol Hepatol.2020;26(1):33-44.   Published online June 27, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0073
                              Supplementary      
45 Vimentin as a potential therapeutic target in sorafenib resistant HepG2, a HCC model cell line
Ankita Makol, Harpreet Kaur, Sakshi Sharma, Shruthi Kanthaje, Ramanpreet Kaur, Anuradha Chakraborti
Clin Mol Hepatol.2020;26(1):45-53.   Published online September 30, 2019     
DOI: https://doi.org/10.3350/cmh.2019.0031
                              Supplementary      
54 Sensitivity of ultrasound in detecting hepatocellular carcinoma in obese patients compared to explant pathology as the gold standard
Jamak Modaresi Esfeh, Kaveh Hajifathalian, Kianoush Ansari-Gilani
Clin Mol Hepatol.2020;26(1):54-59.   Published online November 15, 2019     
DOI: https://doi.org/10.3350/cmh.2019.0039
                              
60 Influence of some methylated hepatocarcinogenesis-related genes on the response to antiviral therapy and development of fibrosis in chronic hepatitis C patients
Waleed Seif Eldin Mohamed Mostafa, Mohammed Hassan Saiem Al-Dahr, Dalia Abdel Hamid Omran, Zeinab Fathy Abdullah, Suzan Hamdy Elmasry, Mohamed Nabil Ibrahim
Clin Mol Hepatol.2020;26(1):60-69.   Published online October 22, 2019     
DOI: https://doi.org/10.3350/cmh.2019.0051
                              
Letters to the Editor
70 The management of polycystic liver disease by tolvaptan
Tsuneo Takenaka, Soichiro Miura, Masaki Kitajima
Clin Mol Hepatol.2020;26(1):70-73.   Published online June 13, 2019     
DOI: https://doi.org/10.3350/cmh.2019.0026
                                 Cited By 1
74 Hyperammonemic encephalopathy: An unusual presentation of fibrolamellar hepatocellular carcinoma
Nimish Thakral, Douglas A. Simonetto
Clin Mol Hepatol.2020;26(1):74-77.   Published online August 16, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0042
                              
78 Clinical characteristics of portal hypertension complicated by gastroesophageal varices in patients with my- eloproliferative neoplasms
Jaejun Lee, Pil Soo Sung, Ki-Seong Eom, Hyun Yang, Soon Kyu Lee, Aung Hlaing Bwa, Angelo Lozada, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
Clin Mol Hepatol.2020;26(1):78-82.   Published online November 26, 2019     
DOI: https://doi.org/10.3350/cmh.2019.0078
                              
E-Submission
Email Alert
Author's Index
EndNote Style file download
The Korean Association for the Study of the Liver
The Liver Week 2019
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
DOAJ
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
ORCID
MeSH on Demand
COPE
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Association for the Study of the Liver. All rights reserved.         
COUNTER
TODAY : 471
TOTAL : 299135